Surgery of the kind studied in the ARMMS-T2D trial of metabolic-bariatric surgery for type 2 diabetes. Health Weight-loss surgery gives lasting diabetes remission in long-term trial Mono Scoops 2d In the ARMMS-T2D trial, 58 percent of people with type 2 diabetes assigned to metabolic-bariatric surgery achieved remission, against 3 percent assigned to medical and lifestyle management, over a median follow-up of 11 years. Read Full Story
